Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide

N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide is listed in the pharmaceutical impurity collection under CAS 209473-00-7. Its represented structure has formula C17H15Cl2NO and a calculated molecular weight of 320.22 g/mol.

2D chemical structure

N + O - C l C l

Chemical identity

Catalog name
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide
Common name
Not available
Chemical name
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide
CAS
209473-00-7
SMILES
C[N+]([O-])=C1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21
InChI
InChI=1S/C17H15Cl2NO/c1-20(21)17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12H,7,9H2,1H3
InChIKey
CZYYNFHEAXHXGV-UHFFFAOYSA-N
Associated API
Sertraline Hydrochloride

Record ID: A75d98f3b2e31

Computed properties

C17H15Cl2NO Molecular formula
320.219 g/molMolecular weight
319.0531 DaMonoisotopic exact mass
26.07 ŲTopological polar surface area
4.8483 Calculated LogP (Wildman–Crippen)
87.6414 cm³/molMolar refractivity (Wildman–Crippen)
1 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight320.21950.15
Calculated LogP (Wildman–Crippen)4.848388.27
Topological polar surface area26.0710.16
Hydrogen-bond acceptors14.43
Hydrogen-bond donors011.28
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC17H15Cl2NOdimensionless
Molecular weight320.219g/mol
Monoisotopic exact mass319.0531Da
Topological polar surface area26.07Ų
Calculated LogP (Wildman–Crippen)4.8483dimensionless
Molar refractivity (Wildman–Crippen)87.6414cm³/mol
Hydrogen-bond acceptors1count
Hydrogen-bond donors0count
Rotatable bonds (strict)1count
Heavy atoms21count
Heteroatoms4count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.2353fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area133.7675Ų
Valence electrons108count
Radical electrons0count
Bertz complexity720.4801index
Balaban J2.113index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide

Qualification and safety assessment of N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide

Explore toxicological qualification of N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide and ICH M7 mutagenic impurity assessment of N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide and acceptable intake and limit justification for N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine N-Oxide

Explore Altox services and software through the Altox Pharma-Hub.